Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma

Journal of International Medical Research

Volumn 40, Issue 5, 2012, Pages 1966-1972

  Xie, Z W ^a   Zhang, Y N ^a   Wan, Shu ^a   Xu, W Z ^a   Chen, J ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Contraception; Haemoglobin concentration; Levonorgestrel releasing intrauterine device; Menstrual blood loss; Uterine leiomyoma; Uterine volume

Indexed keywords

HEMOGLOBIN; CONTRACEPTIVE AGENT; LEVONORGESTREL;

ABSENCE OF COMPLICATIONS; ADULT; AGE; AMENORRHEA AND OLIGOMENORRHEA; ANEMIA; ARTICLE; ASSESSMENT OF HUMANS; BLOOD VOLUME; BREAST TENDERNESS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DEVICE THERAPY; FEMALE; FEMALE GENITAL TRACT PARAMETERS; HEMOGLOBIN DETERMINATION; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE DEVICE DISPLACEMENT; INTRAUTERINE DEVICE EXPULSION; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MEDICAL DEVICE COMPLICATION; MENORRHAGIA; MENSTRUATION; PELVIC INFLAMMATORY DISEASE; PELVIC PAIN; PICTORIAL BLOOD LOSS ASSESSMENT CHART; PREGNANCY; REPRODUCTION; SPOTTING; UTERINE BLEEDING PATTERN; UTERINE VOLUME; UTERUS BLEEDING; UTERUS MYOMA; INTRAUTERINE CONTRACEPTIVE DEVICE; LEIOMYOMA; MIDDLE AGED; PATHOPHYSIOLOGY; UTERUS CANCER;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEIOMYOMA; LEVONORGESTREL; MENORRHAGIA; MENSTRUATION; MIDDLE AGED; UTERINE NEOPLASMS;

EID: 84880618617     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006051204000538     Document Type: Article

References (26)

1. Zapata LB, Paulen ME, Cansino C, et al: Contraceptive use among women with inflammatory bowel disease: a systematic review. Contraception 2010; 82: 72-85.
2. Verkauf BS: Myomectomy for fertility enhancement and preservation. Fertil Steril 1992; 58: 1-15.
3. Rosa e Silva JC, de Sá Rosa e Silva AC, Cândido dos Reis FJ, et al: Use of a levonorgestrelreleasing intrauterine device for the symptomatic treatment of uterine myomas. J Reprod Med 2005; 50: 613-617.
4. Monteiro I, Bahamondes L, Diaz J, et al: Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study. Contraception 2002; 65: 325-328.
5. Grigorieva V, Chen-Mok M, Tarasova M, et al: Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 2003; 79: 1194-1198.
6. Stewart A, Cummins C, Gold L, et al: The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. BJOG 2001; 108: 74-86.
7. Zapata LB, Whiteman MK, Tepper NK, et al: Intrauterine device use among women with uterine fibroids: a systematic review. Contraception 2010; 82: 41-55.
8. Ikomi A, Mansell E, Spence-Jones C, et al: Treatment of menorrhagia with the levonorgestrel intrauterine system: can we learn from our failures? J Obstet Gynaecol 2000; 20: 630-631.
9. Maruo T, Matsuo H, Samoto T, et al: Effects of progesterone on uterine leiomyoma growth and apoptosis. Steroids 2000; 65: 585-592.
10. Higham JM, O’Brien PM, Shaw RW: Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-739.
11. Soysal S, Soysal ME: The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial. Gynecol Obstet Invest 2005; 59: 29-35.
12. Gunes M, Ozdegirmenci O, Kayikcioglu F, et al: The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study. J Minim Invasive Gynecol 2008; 15: 735-738.
13. Magalhães J, Aldrighi JM, de Lima GR: Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 2007; 75: 193-198.
14. Murat Naki M, Tekcan C, Ozcan N, et al: Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes. Fertil Steril 2010; 94: 371-374.
15. Critchley HO, Wang H, Jones RL, et al: Morphological and functional features of endometrial decidualization following longterm intrauterine levonorgestrel delivery. Hum Reprod 1998; 13: 1218-1224.
16. Wildemeersch D, Schacht E: The effect on menstrual blood loss in women with uterine fibroids of a novel “frameless” intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Eur J Obstet Gynecol Reprod Biol 2002; 102: 74-79.
17. Sayed GH, Zakherah MS, El-Nashar SA, et al: A randomized clinical trial of a levonorgestrelreleasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia. Int J Gynaecol Obstet 2011; 112: 126-130.
18. Jindabanjerd K, Taneepanichskul S: The use of levonorgestrel-IUD in the treatment of uterine myoma in Thai women. J Med Assoc Thai 2006; 89(suppl 4): S147-S151.
19. Rein MS: Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 2000; 108(suppl 5): 791-793.
20. Pavlovich SV, Volkov NI, Burlev VA: Proliferative activity and level of steroid hormone receptors in the myometrium and myoma nodes in different phases of menstrual cycle. Bull Exp Biol Med 2003; 136: 396-398.
21. Cepický P, Cibula D, Dvorák V, et al: Recommendations for the levonorgestrel intrauterine system (LNG-IUS). 2006. Ceska Gynekol 2007; 72: 149-150 [in Czech].
22. Mercorio F, De Simone R, Di Spiezio Sardo A, et al: The effect of a levonorgestrel-releasing intrauterine device in the treatment of myomarelated menorrhagia. Contraception 2003; 67: 277-280.
23. Wildemeersch D, Schacht E: Treatment of menorrhagia with a novel ‘frameless’ intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Eur J Contracept Reprod Health Care 2001; 6: 93-101.
24. Diaz J, Bahamondes L, Monteiro I, et al: Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena®) in Campinas, Brazil. Contraception 2000; 62: 59-61.
25. Andersson K, Odlind V, Rybo G. Levonorgestrelreleasing and copper-releasing (Nova-T) IUDs during five years of use: a randomized comparative trial. Contraception 1994; 49: 56-72.
26. Kriplani A, Singh BM, Lal S, et al: Efficacy, acceptability and side-effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynaecol Obstet 2007; 97: 190-194.